Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Butyric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.81 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.81 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.81 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.81 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.81 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | PPARG | P37231 | 7/20 | 0.50 |
| ▸ | PPARD | Q03181 | 7/20 | 0.50 |
| ▸ | PPARA | Q07869 | 7/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL6507304 | 0.97 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL5571639 | 0.97 | FFAR3 (0.87) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL49424 | 0.97 | — | — | |
| Butyric Acid SCHEMBL2123451 | 0.94 | FFAR3 (0.81) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL27662216 | 0.94 | FFAR3 (0.81) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL10520334 | 0.94 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL28476290 | 0.94 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL1650329 | 0.94 | — | — | |
| Butyric Acid SCHEMBL2234517 | 0.94 | — | — | |
| Butyric Acid SCHEMBL2230669 | 0.94 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10568931-B2 | Pharmaceutical composition comprising ginseng extracts for prevention and treatment of ophthalmological diseases | GINTONIN KU BIOTECH CO., LTD. (KR) | 2020-02-25 | — | — | US | disclosed |
| EP-2780310-A1 | PROCESS FOR RECOVERY OF ETHANOL FROM HYDROGENOLYSIS PROCESS | Celanese International Corporation (US) | 2014-09-24 | — | — | EP | disclosed |
| US-8748673-B2 | Process of recovery of ethanol from hydrogenolysis process | CELANESE INTERNATIONAL CORPORATION (US) | 2014-06-10 | — | — | US | disclosed |
| US-8563052-B2 | Method for preparing gintonin, which is a novel glycolipoproetin from panax ginseng, and gintonin, which is a novel glycolipoprotein, prepared by the method | KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP. (KR) | 2013-10-22 | — | — | US | disclosed |
| US-20130131398-A1 | Process of Recovery of Ethanol From Hydrogenolysis Process | CELANESE INTERNATIONAL CORPORATION (US) | 2013-05-23 | — | — | US | disclosed |
| WO-2013074570-A1 | PROCESS FOR RECOVERY OF ETHANOL FROM HYDROGENOLYSIS PROCESS | CELANESE INTERNATIONAL CORPORATION (US) | 2013-05-23 | — | — | WO | disclosed |
| US-20120165266-A1 | METHOD FOR PREPARING GINTONIN, WHICH IS A NOVEL GLYCOLIPOPROETIN FROM PANAX GINSENG, AND GINTONIN, WHICH IS A NOVEL GLYCOLIPOPROTEIN, PREPARED BY THE METHOD | KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP. (KR) | 2012-06-28 | — | — | US | disclosed |
| US-6773902-B1 | Method for preparing lysophosphatidylethanolamine | DOOSAN CORPORATION (KR) | 2004-08-10 | — | — | US | disclosed |
| US-5721115-A | GENETIC ENGINEERING | ANTEX BIOLOGICS, INC. (US) | 1998-02-24 | — | — | US | disclosed |
| US-5679547-A | COMPLEXING | ANTEX BIOLOGICS FORMERLLY MICROCARB INC. (US) | 1997-10-21 | — | — | US | disclosed |
| US-4539202-A | SYNERGISTIC MIXTURE WITH PENICILLINS | BEECHAM GROUP P.L.C. (GB) | 1985-09-03 | — | — | US | disclosed |
| US-4524073-A | β-Lactam compounds | BEECHAM GROUP P.1.C. (GB) | 1985-06-18 | — | — | US | disclosed |
| US-4444754-A | SYNERGISTIC WITH PENICILLIN | BEECHAM GROUP LIMITED (GB) | 1984-04-24 | — | — | US | disclosed |
| EP-0101199-A1 | Beta-lactam compounds | BEECHAM GROUP PLC (GB) | 1984-02-22 | — | — | EP | disclosed |
| EP-0021836-B1 | CLAVULANIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1983-05-11 | — | — | EP | disclosed |
| EP-0068617-A1 | Derivatives of clavulanic acid, a process for their preparation and their use | BEECHAM GROUP PLC (GB) | 1983-01-05 | — | — | EP | disclosed |
| US-4359473-A | α-Amino deoxy clavulanic acid antibacterial agents | BEECHAM GROUP LIMITED (GB) | 1982-11-16 | — | — | US | disclosed |
| US-4313008-A | FROM A CHLORODEOXY-D-SACCHARIDE | TATE & LYLE LTD. (GB) | 1982-01-26 | — | — | US | disclosed |
| US-4301168-A | BACTERICIDES, BETA-LACTAMASE INHIBITORS | BEECHAM GROUP LIMITED (GB) | 1981-11-17 | — | — | US | disclosed |
| US-RE29224-E | DIISOCYANATES, DIAMINES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | disclosed |